美他沙酮
5-((3,5-Dimethylphenoxy)methyl)oxazolidin-2-one;5-(3,5-xylyloxymethyl)-2-oxazolidone;Metaxalowe;Metaxalone;5-(3,5-dimethylphenoxymethyl)-2-oxazolidinone;Metaxalone solution;5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one;5-[(3,5-Xylyloxy)methyl]-2-oxazolidinone;AHR438;NSC170959;Metaxalon;Metazalone;Metazolone;5-[(3,5-Dimethylphenoxy)methyl]oxazolidin-2-one;Zorane;AHR-438;Skelaxi;SKELAXIN;cl39,148;METAXOLONE;AHR 438;NSC 170959;CL 39,148;Methaxalonum;Methoxolone;Metaxalonum [Latin];Metassalone [DCIT];Metaxalonum [INN-Latin];Metaxalonum;Metaxalona [INN-Spanish];Metassalone;Metaxalona;2-Oxazolidinone, 5-[(3,5-dimethylphenoxy)methyl]-;5-(3,5-Xyloloxymethyl)oxazolidin-2-one;Metaxalona [Spanish];2-Oxazolidinone, 5-((3,5-xylyloxy)methyl)-;5-[(3,5-Dimethylphenoxy)methyl]-1,;5-(3,5-Dimethylphenoxymethyl)-2-oxazolidinone;METAXALONE;HMS1922H07;SpecPlus_000656;5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one #;METAXALONE [MI];Flexura;KBioSS_002221;2-Oxazolidinone,5-dimethylphenoxy)methyl]-;SBI-0052859.P002;5-{[(3,5-dimethylphenyl)oxy]methyl}-1,3-oxazolidin-2-one;Metaxalone, United States Pharmacopeia (USP) Reference Standard;NSC758703;Tox21_111428;Skelaxin;NSC-170959;5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one;.meta.Zalone;1665-48-1;Spectrum_001741;SPECTRUM1504229;CHEMBL1079604;METAXALONE [INN];AKOS009035315;DB00660;Spectrum5_001685;Metaxalonum (INN-Latin);SR-05000001978-1;Metaxolone;METAXALONE [USP-RS];METAXALONE [USAN];Spectrum4_000612;KBioGR_001164;metaxalone tablet;SPBio_000595;5-((3,5-Dimethylphenoxy)methyl)-2-oxazolidinone;HSDB 3236;Tox21_111428_1;s3730;BRD-A94709349-001-03-4;BRN 0884592;METAXALONE (USP-RS);METAXALONE [MART.];DTXSID3023269;GTPL7609;FS-3218;2-Oxazolidinone, 5-((3,5-dimethylphenoxy)methyl)-;METAXALONE [VANDF];DTXCID103269;EN300-119839;NCGC00095116-05;SCHEMBL34908;SMR001821638;MFCD00867700;5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one;.meta.Xalone;HMS2093C22;BCP28377;NCGC00095116-02;Spectrum2_000548;1NMA9J598Y;M2578;FT-0603568;METAXALONE [ORANGE BOOK];AB00053284_04;Metaxalonum (Latin);CCG-39592;METAXALONE (MART.);WLN: T5MVOTJ D1OR C1 E1;Skelaxin (TN);NS00000535;Metaxalone, >=98% (HPLC);SY052772;Oprea1_438855;METAXALONE [WHO-DD];KBio2_007357;KBio2_002221;5-[(3,5-Dimethylphenoxy)methyl]-2-oxazolidinone;2-Oxazolidinone,5-xylyloxy)methyl]-;NCGC00095116-01;KBio1_001696;A810747;SR-05000001978;Z106952910;Spectrum3_001666;C07934;NSC-758703;Metaxalona (INN-Spanish);METAXALONE [USP MONOGRAPH];CAS-1665-48-1;.meta.Xalon;EINECS 216-777-6;J-010295;SR-05000001978-3;5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone;KBio2_004789;METAXALONE (USP MONOGRAPH);METAXALONE [HSDB];Metaxalone (USP/INN);CHEBI:6797;BSPBio_003451;2-Oxazolidinone, 5-[(3,5-xylyloxy)methyl]-;Pharmakon1600-01504229;HY-B0678;5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one;AM20060525;BRD-A94709349-001-02-6;KBio3_002671;5-((3,5-Dimethylphenoxy)methyl)-1,3...